Table 1 Demographic and clinical characteristics for methamphetamine (METH) users and healthy controls.
From: Shortened leukocyte telomere length in young adults who use methamphetamine
METH users | Healthy controls | P-value | |
|---|---|---|---|
(N = 187) | (N = 159) | ||
Age (years), mean (SD) | 29.52 (2.89) | 28.99 (2.89) | 0.09b |
Sex | |||
Female, N (%) | 27 (14.4) | 33 (20.8) | 0.12c |
Marital status | |||
Married, N (%) | 25 (13.6) | 30 (19.1) | 0.17c |
Education (years), median (Q1, Q3) | 10 (9, 12) | 16 (16, 16) | <0.0001d |
Smoking | |||
Ever smoker, N (%) | 160 (94.7) | 36 (22.6) | <0.0001c |
Cumulative smoking dose (pack-years), median (Q1, Q3) | 11 (5, 20) | ||
ACEs scorea, median (Q1, Q3) | 2 (1, 3) | 1 (0, 2) | <0.0001d |
METH use variables | |||
Onset age of METH use (years), median (Q1, Q3) | 23 (18, 28) | ||
Duration of METH use (months), median (Q1, Q3) | 10 (3, 59) | ||
Maximum frequency of METH use (times/month), median (Q1, Q3) | 12 (4, 30) | ||
Polysubstance use, N (%) | 68 (36.4) | ||
Relative T/S ratio, median (Q1, Q3) | 0.70 (0.31, 1.06) | 1.01 (0.63, 2.04) | <0.0001d |
